Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

摘要

BackgroundThis study describes a repeated measures prediction index to identify patients at high risk of ≥ grade 2 hand-foot skin reaction (HFSR) before each week of sorafenib therapy.